The development of noninvasive methods to detect and monitor tumors continues to be a
major challenge in oncology. We used digital polymerase chain reaction–based technologies …

Malignant cells, like all actively growing cells, must maintain their telomeres, but genetic
mechanisms responsible for telomere maintenance in tumors have only recently been …

Transitional cell carcinoma (TCC) is the most common type of bladder cancer. Here we
sequenced the exomes of nine individuals with TCC and screened all the somatically mutated …

The field of research in bladder cancer has seen significant advances in recent years. Next-generation
sequencing has identified the genes most mutated in bladder cancer. This wealth …

Because of its availability, ease of collection, and correlation with physiology and pathology,
urine is an attractive source for clinical proteomics/peptidomics. However, the lack of …

Bladder cancer is one of the most common cancers worldwide, with transitional cell carcinoma
(TCC) being the predominant form. Here we report a genomic analysis of TCC by both …

Background Non-invasive methods for diagnosis of urothelial carcinoma have reduced
specificity in patients with non-malignant genitourinary disease or other disorders. We aimed to …

microRNAs (miRNAs) regulate expression by promoting degradation or repressing translation
of target transcripts. miRNA target sites have been catalogued in databases based on …

Metastasis remains the major driver of mortality in patients with cancer. Our growing body of
knowledge regarding this process provides the basis for the development of molecularly …

Reactivation of telomerase, the chromosome end–replicating enzyme, drives human cell
immortality and cancer. Point mutations in the telomerase reverse transcriptase (TERT) gene …